Not applicableStudy completedNCT01381705
What this trial is testing
Biomarkers in Predicting Response to Rituximab Treatment in Samples From Patients With Indolent Follicular Lymphoma
Who this might be right for
Lymphoma
ECOG-ACRIN Cancer Research Group 259